Renee Wegrzyn – Program Manager in the Biological Technologies Office
Dr. Renee Wegrzyn is a Program Manager in the Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA). She is interested in applying the tools of synthetic biology to support biosecurity and outpace infectious disease.
Prior to joining DARPA as a PM, Dr. Wegrzyn was a Senior Lead Biotechnologist at Booz Allen Hamilton, where she led a team that provided scientific and strategic support in the areas of biodefense, biosecurity, disruptive technologies, emerging infectious disease, neuromodulation, and synthetic biology to DARPA and other federal and private institutions. She is a former fellow and active mentor for the UPMC Center for Health Security Emerging Leaders in Biosecurity Initiative. Dr. Wegrzyn also led research and development teams in the biotech industry focused on the development of multiplex immunoassays and peptide-based disease diagnostics.
Dr. Wegrzyn earned her Bachelor of Science and Doctor of Philosophy in Applied Biology with a minor in bioengineering from the Georgia Institute of Technology. She completed her postdoctoral training as an Alexander von Humboldt Fellow in Heidelberg, Germany.